The firm will test strategies and develop/implement a pilot AI drug-discovery solution. Outcomes are expected to be particularly beneficial for small Canadian start-ups and biotechs that do not have the resources to maintain an extensive in-house drug discovery team.
This record is a historical disbursement from Canada's open grants database — it documents a past payment, not an active program accepting applications.
View disbursement record →